Compiled by Efstathios Kastritis, MD
National and Kapodistrian University of Athens
Newly diagnosed MM – Transplant eligible
Newly diagnosed transplant ineligible
Immunotherapy and cellular therapy for myeloma
Minimal Residual Disease
Prognosis – Genetics
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.